160 related articles for article (PubMed ID: 19578614)
1. Immunoreactivity of cytokeratins 7 and 20 in goblet cells and columnar blue cells in patients with endoscopic evidence of Barrett's esophagus.
Cantarelli JC; Fagundes RB; Meurer L; Rocha MP; Nicola A; Kruel CD
Arq Gastroenterol; 2009; 46(2):127-31. PubMed ID: 19578614
[TBL] [Abstract][Full Text] [Related]
2. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
3. Expression of CDX2 and MUC2 in Barrett's mucosa.
Steininger H; Pfofe DA; Müller H; Haag-Sunjic G; Fratianu V
Pathol Res Pract; 2005; 201(8-9):573-7. PubMed ID: 16259110
[TBL] [Abstract][Full Text] [Related]
4. [Cytokeratin immunoreactivity patterns in the diagnosis of Barrett's esophagus].
Wang R; Xie J; Shen Y; Ren T
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1820-3. PubMed ID: 23268419
[TBL] [Abstract][Full Text] [Related]
5. Transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus.
Jiang M; Li H; Zhang Y; Yang Y; Lu R; Liu K; Lin S; Lan X; Wang H; Wu H; Zhu J; Zhou Z; Xu J; Lee DK; Zhang L; Lee YC; Yuan J; Abrams JA; Wang TC; Sepulveda AR; Wu Q; Chen H; Sun X; She J; Chen X; Que J
Nature; 2017 Oct; 550(7677):529-533. PubMed ID: 29019984
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M
Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041
[TBL] [Abstract][Full Text] [Related]
7. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia?
Türkmen IÇ; Başsüllü N; Uraz S; Yerdel MA; Memışoğlu R; Bülbül Doğusoy G
Turk Patoloji Derg; 2012; 28(3):251-8. PubMed ID: 23011828
[TBL] [Abstract][Full Text] [Related]
8. Expression of mucin-2 and correlation with PAS-alcian blue stain in Barrett's esophagus.
Lopes CV; Pereira-Lima J; Hartmann A
Hepatogastroenterology; 2006; 53(70):511-5. PubMed ID: 16995451
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic versus histological diagnosis of Barrett's esophagus: a cross-sectional survey.
Irvanloo G; Fallahi B; Ensani F; Azmi M; Morteza A
Pol J Pathol; 2011 Sep; 62(3):152-6. PubMed ID: 22102072
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of metaplastic non-goblet columnar lined oesophagus shows phenotypic similarities to Barrett's oesophagus: a study in an Asian population.
Srivastava S; Liew MS; McKeon F; Xian W; Yeoh KG; Ho KY; Teh M
Dig Liver Dis; 2014 Feb; 46(2):170-5. PubMed ID: 24290871
[TBL] [Abstract][Full Text] [Related]
11. Non-goblet cell population of Barrett's esophagus: an immunohistochemical demonstration of intestinal differentiation.
Chaves P; Cardoso P; de Almeida JC; Pereira AD; Leitao CN; Soares J
Hum Pathol; 1999 Nov; 30(11):1291-5. PubMed ID: 10571507
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus.
Ormsby AH; Vaezi MF; Richter JE; Goldblum JR; Rice TW; Falk GW; Gramlich TL
Gastroenterology; 2000 Sep; 119(3):683-90. PubMed ID: 10982762
[TBL] [Abstract][Full Text] [Related]
13. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of multilayered epithelium in Barrett's esophagus.
Shields HM; Rosenberg SJ; Zwas FR; Ransil BJ; Lembo AJ; Odze R
Am J Gastroenterol; 2001 Dec; 96(12):3268-73. PubMed ID: 11774935
[TBL] [Abstract][Full Text] [Related]
15. MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction.
McIntire MG; Soucy G; Vaughan TL; Shahsafaei A; Odze RD
Am J Surg Pathol; 2011 Jul; 35(7):1007-13. PubMed ID: 21602660
[TBL] [Abstract][Full Text] [Related]
16. Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barrett's oesophagus in Korea?
Yim HJ; Lee SW; Choung RS; Kim YS; Kim JY; Lee HS; Song CW; Choi JH; Bak YT; Ryu HS; Hyun JH; Kim DS; Kim CH
Eur J Gastroenterol Hepatol; 2005 Jun; 17(6):611-6. PubMed ID: 15879722
[TBL] [Abstract][Full Text] [Related]
17. Math1/Atoh1 contributes to intestinalization of esophageal keratinocytes by inducing the expression of Muc2 and Keratin-20.
Kong J; Crissey MA; Sepulveda AR; Lynch JP
Dig Dis Sci; 2012 Apr; 57(4):845-57. PubMed ID: 22147253
[TBL] [Abstract][Full Text] [Related]
18. Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up.
Zhang X; Westerhoff M; Hart J
Mod Pathol; 2015 May; 28(5):654-61. PubMed ID: 25412842
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type.
Offner FA; Lewin KJ; Weinstein WM
Hum Pathol; 1996 Sep; 27(9):885-9. PubMed ID: 8816881
[TBL] [Abstract][Full Text] [Related]
20. Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma.
Chaves P; Cruz C; Dias Pereira A; Suspiro A; de Almeida JC; Leitão CN; Soares J
Dis Esophagus; 2005; 18(6):383-7. PubMed ID: 16336609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
